US Patent Issued to RESQ Pharmaceuticals on June 17 for "Methods and compositions for treating edema refractory to oral diuretics" (North Carolina, California Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,731, issued on June 17, was assigned to RESQ Pharmaceuticals LLC (Orange, Calif.).

"Methods and compositions for treating edema refractory to oral diuretics" was invented by Balasingam Radhakrishnan (Chapel Hill, N.C.), Ben Esque (Huntington Beach, Calif.), Wei Lin (San Diego) and Andrew Xian Chen (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention features methods and compositions for the intranasal, sublingual, and subcutaneous administration of bumetanide for the treatment of subjects suffering from edema refractory to oral diuretics."

The patent was filed on Oct. 15, 2024, under Application No. 18/916,471.

*For furt...